Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7563869 Substance specific to human PD-1

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
January 22, 2004
0
Date of Patent
July 21, 2009
0
Patent Application Number
10543323
0
Patent Citations Received
‌
US Patent 12091461 Bispecific antibody
0
‌
US Patent 12084495 Compositions and methods for modulating LAIR signal transduction
0
‌
US Patent 11660340 Combination therapy using T cell redirection antigen binding molecule against cell having immunosuppressing function
0
‌
US Patent 11685775 Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody
0
‌
US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors
0
‌
US Patent 11708412 Methods for treating hematologic cancers
0
‌
US Patent 11753458 CTLA-4 variant immunomodulatory proteins and uses thereof
‌
US Patent 11786529 Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK inhibitors
‌
US Patent 11827704 Antibody molecules to PD-1 and uses thereof
0
‌
US Patent 11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7563869
0
Patent Primary Examiner
‌
Ilia Ouspenski
0

Find more entities like US Patent 7563869 Substance specific to human PD-1

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo